62 Pa. Stat. § 2922

Current through Pa Acts 2024-53, 2024-56 through 2024-111
Section 2922 - Definitions

The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:

"Approved participating pharmacy." A pharmacy approved by the State Board of Pharmacy for the purpose of dispensing unused cancer drugs to participating entities and to patients who are indigent.

"Board." The State Board of Pharmacy of the Commonwealth.

"Cancer drug." A prescription drug used to treat any of the following:

(1) Cancer or its side effects.
(2) The side effects of a prescription drug used to treat cancer or its side effects.

"Closed drug delivery system." A system in which the actual control of a unit dose medication is maintained by a health care facility, health clinic, hospital, pharmacy or physician's office rather than an individual patient.

"Health care facility." A for-profit or nonprofit entity providing clinically related health services, including those operated by the Commonwealth or its political subdivisions and including a general or special hospital, including psychiatric hospitals, rehabilitation hospitals, ambulatory surgical facilities, long-term care nursing facilities, a hospice, a cancer treatment center using radiation therapy on an ambulatory basis and an inpatient drug and alcohol treatment facility.

"Health clinic." A for-profit or nonprofit clinic providing health services.

"Hospital." An entity licensed as a hospital under the act of July 19, 1979 (P.L. 130, No. 48) , known as the Health Care Facilities Act.

"Pharmacist." A pharmacist licensed by the Commonwealth.

"Pharmacy." A pharmacy licensed by the Commonwealth.

"Physician's office." The office of a person licensed to practice medicine and surgery or osteopathic medicine and surgery.

"Prescribing practitioner." A health care practitioner licensed under the laws of this Commonwealth who is authorized to prescribe cancer drugs.

"Prescription drug." A drug requiring a prescription in this Commonwealth.

"Program." The Cancer Drug Repository Program established in section 3.

"Unit dose system." A system wherein all individually sealed unit doses are physically connected as a unit.

62 P.S. § 2922

2008, May 13, P.L. 139, No. 14, §2, effective in 60 days [ 7/14/2008].